Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells

Kayla M. Borland, Safnas F. AbdulSalam, Morwena J. Solivio, Matthew P. Burke, Patrick R. Wolfkiel, Sean M. Lawson, Courtney A. Stockman, Joel M. Andersen, Skyler Smith, Julia N. Tolstolutskaya, Purujit N. Gurjar, Aron P. Bercz, Edward J. Merino, Vladislav A. Litosh

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells'. Together they form a unique fingerprint.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science